Craig A Harrison (Craig Harrison)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Topics

Epithelial Mesenchymal Transition

Transforming Growth Factor

Top Venues

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Experimental dermatology

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

William A Stocker, James A Howard, Shreya Maskey, Haitong Luan, Sophie G Harrison, Kaitlin N Hart, Lucija Hok, Thomas B Thompson, Kelly L Walton, Craig A Harrison
Characterization of the molecular mechanisms that govern anti-Müllerian hormone synthesis and activity. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (1) (2023)
William A Stocker, James A Howard, Shreya Maskey, Haitong Luan, Sophie G Harrison, Kaitlin N Hart, Lucija Hok, Thomas B Thompson, Kelly L Walton, Craig A Harrison
Characterization of the molecular mechanisms that govern anti-Müllerian hormone synthesis and activity. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (1) (2023)
William A Stocker, James A Howard, Shreya Maskey, Haitong Luan, Sophie G Harrison, Kaitlin N Hart, Lucija Hok, Thomas B Thompson, Kelly L Walton, Craig A Harrison
Characterization of the molecular mechanisms that govern anti-Müllerian hormone synthesis and activity. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (1) (2023)
William A Stocker, James A Howard, Shreya Maskey, Haitong Luan, Sophie G Harrison, Kaitlin N Hart, Lucija Hok, Thomas B Thompson, Kelly L Walton, Craig A Harrison
Characterization of the molecular mechanisms that govern anti-Müllerian hormone synthesis and activity. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (1) (2023)
William A Stocker, James A Howard, Shreya Maskey, Haitong Luan, Sophie G Harrison, Kaitlin N Hart, Lucija Hok, Thomas B Thompson, Kelly L Walton, Craig A Harrison
Characterization of the molecular mechanisms that govern anti-Müllerian hormone synthesis and activity. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (1) (2023)
Kelly L Walton, Monica P Goney, Zoe Peppas, Jessica M Stringer, Amy Louise Winship, Karla J Hutt, Georgia Goodchild, Shreya Maskey, Karen L Chan, Emilie Brûlé, Daniel J Bernard, William A Stocker, Craig A Harrison
Inhibin Inactivation in Female Mice Leads to Elevated FSH Levels, Ovarian Overstimulation, and Pregnancy Loss. Endocrinology 163 (4) (2022)
Emilie Brûlé, Ying Wang, Yining Li, Yeu-Farn Lin, Xiang Zhou, Luisina Ongaro, Carlos A I Alonso, Evan R S Buddle, Alan L Schneyer, Chang Hyeock Byeon, Cynthia S Hinck, Natalia Mendelev, John P Russell, Mitra Cowan, Ulrich Boehm, Frederique Ruf Zamojski, Michel Zamojski, Cynthia Lilian Andoniadou, Stuart C Sealfon, Craig A Harrison, Kelly L Walton, Andrew P Hinck, Daniel J Bernard
TGFBR3L is an inhibin B co-receptor that regulates female fertility. Science advances 7 (51) (2021)
Seungmin Ham, Craig A Harrison, David de Kretser, Euan Morrison Wallace, Graeme Southwick Oam, Peter Temple-Smith
Potential treatment of keloid pathogenesis with follistatin 288 by blocking the activin molecular pathway. Experimental dermatology 30 (3) (2020)
Kieren D Marini, David R Croucher, Rachael A McCloy, Vijesh Vaghjiani, Alvaro Gonzalez Rajal, Jordan F Hastings, Venessa T Chin, Anette Szczepny, Kaja Kostyrko, Cesar Marquez, W Samantha Nilanthi Jayasekara, Muhammad Alamgeer, Vishal Boolell, Jeremy Z R Han, Todd Waugh, Hong Ching Lee, Samantha Richelle Oakes, Beena Kumar, Craig A Harrison, Mark P Hedger, Nirmal Lorensuhewa, Badia Kita, Ross Barrow, Bruce W S Robinson, David M de Kretser, Jianmin Wu, Vinod Ganju, E Alejandro Sweet-Cordero, Andrew Burgess, Luciano G Martelotto, Fernando J Rossello, Jason E Cain, D Neil Watkins
Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy. Science translational medicine 10 (451) (2019)